Michael Dodds, PhD Executive Director, Integrated Drug Development

Specializing in pharmacometrics application to complex biotechnology products since 2005, Mike’s research focuses on the application of mathematical models of biology, (patho)-physiology, pharmacology and disease that quantify beneficial and undesirable interactions between drugs and patients to predict outcomes. He has held roles at ZymoGenetics and Amgen.